| CAPE CORAL, Fla., Nov. 1, 2011 /PRNewswire/ -- Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk) announced that it will purchase the exclusive rights to a formula that was developed to restore proper kidney function in people with chronic kidney disease (CKD). Chronic kidney disease is a growing health problem in the United States. A report by the Centers for Disease Control (CDC) determined that 16.8% of all adults above the age of 20 years have chronic kidney disea...continued MILV |
Tuesday, November 1, 2011
Nature's Bioceuticals Tears Into the Multi-Billion Dollar Chronic Kidney Disease Market
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment